What Is CBG? CBG, CBN and CBC Explained: Origins, Research and Labels

What is CBG? Cannabigerol (CBG) is a cannabinoid that forms from CBGA, the acid the hemp plant uses as the starting material for THC, CBD and CBC. CBN (cannabinol) is different: it forms when THC breaks down with heat, light and oxygen. CBC (cannabichromene) is a third compound built from the same CBGA starting point. All three are called minor cannabinoids because most plants contain far less of them than CBD or THC, and all three have much less human research behind them.

This guide explains where each one comes from, what studies have actually measured, how the 2026 change to the federal hemp definition touches them and what to check on a label. It is general information, not medical advice.

What is CBG?

CBG is the neutral form of cannabigerolic acid (CBGA). A 2021 review in the Journal of Cannabis Research describes CBGA as the central intermediate that plant enzymes convert into THCA, CBDA and CBCA. When hemp is heated or dried, those acids lose a carboxyl group and become THC, CBD and CBC; CBGA that was not converted becomes CBG. Researchers sometimes call CBGA the mother of all cannabinoids for this reason. Some brands source CBG from hemp bred to be rich in it; Neurogan, for example, says its CBG comes from CBG-rich white hemp flower.

What is CBN?

CBN has no enzyme of its own. The same 2021 review explains that THCA and THC oxidize into CBNA and CBN when exposed to heat, oxygen and light. Because no CBN-rich plants exist, legal commentators and university researchers describe commercial CBN as usually made by converting other cannabinoids, such as THC or CBD, into CBN. That production detail matters under the new federal hemp definition, covered below.

What is CBC? The cannabichromene cannabinoid

CBC is the third major branch of the CBGA pathway. The enzyme CBCA synthase turns CBGA into cannabichromenic acid (CBCA), and heat converts CBCA into neutral CBC, according to a 2024 review in the Journal of Pharmacology and Experimental Therapeutics. That review, funded by the National Institutes of Health, concluded that studies on CBC remain limited and that more work is needed on its safety and tolerability in humans.

What research exists on CBG, CBN and CBC

Most studies on these compounds are laboratory or animal experiments, which cannot show what happens in people. The human studies we found are small, short or both:

• CBG (2024). A double-blind, placebo-controlled crossover trial in Scientific Reports gave 34 healthy adults who already used cannabis a single 20 mg dose of hemp CBG or placebo. Self-rated anxiety scores were lower after CBG in the following hour, and no intoxication was detected. The CBG was supplied by a company that funded the study and whose founder was a co-author. The authors noted the non-clinical sample, the single low dose and remote testing as limits, and said only two earlier human CBG trials existed.
• CBN (2024). A randomized trial in Experimental and Clinical Psychopharmacology followed 293 adults who rated their sleep as poor for seven nights. Those given 20 mg of CBN reported fewer awakenings and lower sleep-disturbance scores than placebo, but there was no difference in time to fall asleep, and adding CBD did not change results. The study was funded by Canopy Growth, which employed most of the authors.
• CBN (2026). A smaller crossover trial in the Journal of Sleep Research gave 20 adults with diagnosed insomnia one night each of 30 mg CBN, 300 mg CBN or placebo. Neither dose significantly changed time awake after falling asleep, the main outcome, and the authors called for larger, longer trials.
• CBC. We found no completed randomized trials of CBC’s effects in people; the 2024 review above describes mostly preclinical work.

Taken together, the evidence is early and mixed. These studies do not show that any CBG, CBN or CBC product will have a particular effect for you.

Legal status: why CBN is the tricky one

CBG, CBN and CBC are all compounds the cannabis plant can produce. Under the federal hemp definition signed in November 2025, set to take effect December 11, 2026 after a short delay, finished hemp products are judged by their total THC per container, capped at 0.4 mg, and products with cannabinoids synthesized or manufactured outside the plant are excluded, according to the Congressional Research Service. Two points follow:

• Full-spectrum CBG, CBN or CBC products contain some natural THC, so the amount per container matters.
• Because commercial CBN is often converted from other cannabinoids, how the new exclusion applies to CBN depends on how it was made and on lists FDA was directed to publish. As of early September 2026, those lists had not appeared.

State laws also apply and vary. Check your state’s rules, and consult a lawyer or regulator for legal questions.

How to read a CBG, CBN or CBC label

• Milligrams of each cannabinoid per serving. Many products pair a minor cannabinoid with CBD, so look for each number separately, not only a combined total.
• Ratio. A 1:1 product has equal amounts of both cannabinoids; a 3:1 CBD:CBC product has three times as much CBD.
• Spectrum. Full spectrum includes trace THC and may affect a drug test; see full spectrum vs broad spectrum vs isolate.
• Certificate of analysis. Confirm that the lab measured the minor cannabinoid itself, plus THC and THCA, for the same batch. Our guide on reading a CBD certificate of analysis shows where to look.
• Other ingredients and warnings. Check carrier oils such as coconut, gelatin in softgels, and label warnings about driving, pregnancy and medicines.

CBG, CBN and CBC products at Peptide Labs

These examples are described from the brands’ own listings; follow each label and ask a healthcare provider before use if you take medicines.

• Extract Labs Organic CBG Oil: full spectrum, 1,000 mg CBG and 1,000 mg CBD per 30 mL bottle in coconut oil.
• Neurogan CBN Oil: full spectrum, 50 mg CBD and 50 mg CBN per half-dropper serving; the label warns against use before driving.
• Extract Labs CBC Capsules: full spectrum, 30 mg CBD and 10 mg CBC per softgel; contains bovine gelatin.

Neurogan CBG gummies and CBD + CBN gummies are also available. Browse by format in oils and tinctures, gummies and capsules and softgels.

Frequently Asked Questions

Questions about a label? Contact us or read does CBD show up on a drug test. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Last reviewed September 2026.